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A	  computa*on	  model	  of	  a	  striatal	  dopaminergic	  varicosity	  was	  
used.	  In	  the	  ﬁgure	  below,	  processes	  that	  change	  species	  within	  
a	  compartment,	  usually	  enzymes,	  are	  shown	  as	  ovals.	  
Processes	  moving	  molecules	  across	  membranes	  are	  shown	  as	  
arrows.	  Processes	  aﬀec*ng	  only	  dopamine	  are	  shown	  as	  white	  
symbols.	  Processes	  aﬀec*ng	  only	  DOPAC	  are	  shown	  as	  black	  
symbols.	  
Abbrevia*ons	  are	  TH,	  tyrosine	  hydroxylase;	  MAO,	  monoamine	  
oxidase,	  DAT,	  dopamine	  transporter;	  revDAT,	  reverse	  of	  DAT;	  
VMAT,	  vesicular	  monoamine	  transporter;	  DcD,	  processes	  that	  
remove	  DOPAC	  from	  cytosol;	  DeD,	  processes	  that	  remove	  
DOPAC	  from	  extracellular	  compartment.	  
Strategy	  used	  to	  complete	  the	  simula3ons	  includes	  	  
- Quan*ta*ve	  formulas	  involving	  rate	  constants,	  aﬃni*es,	  
and	  capaci*es	  are	  assigned	  to	  each	  parameter	  (arrows	  
and	  ovals	  in	  the	  diagram).	  	  
o Determined	  using	  known	  biochemical	  data	  
whenever	  possible	  	  
o Determined	  by	  trial	  and	  error	  if	  necessary	  
- An	  ini*al	  value	  is	  assigned	  for	  dopamine	  and	  DOPAC	  in	  
all	  compartments	  	  
- At	  each	  program	  itera*on:	  
o  The	  amount	  of	  dopamine	  and	  DOPAC	  in	  each	  
compartment	  is	  calculated	  by	  adding	  or	  
subtrac*ng	  to	  the	  previous	  level	  the	  amount	  
added	  or	  removed	  from	  compartments	  by	  
synthesis/metabolism	  and	  how	  much	  dopamine	  
and	  DOPAC	  was	  moved	  between	  compartments	  by	  
transport/diﬀusion	  	  
- Drug	  eﬀects	  simulated	  	  by	  changing	  parameter	  values	  
thought	  to	  be	  impacted	  by	  drug	  
The	  big	  picture	  is	  to	  explain	  the	  eﬀects	  of	  an*psycho*c	  
drugs	  on	  striatal	  dopaminergic	  varicosi*es.	  
Dopamine	  neurons	  are	  involved	  in	  
- interpre*ng	  reward/pleasure	  
- conver*ng	  mo*va*on	  into	  ac*on	  
- comparing	  expected	  and	  predicted	  outcomes	  
- ini*a*ng	  voluntary	  movements	  
An3psycho3c	  drugs	  
- control	  many	  symptoms	  of	  schizophrenia	  
- are	  antagonists	  at	  dopamine	  D2	  receptors	  
- vary	  substan*ally	  in	  eﬀects	  on	  dopamine	  varicosi*es	  
Literature	  Data	  Review	  
- All	  an*psycho*cs	  
o No	  eﬀect	  *ssue	  dopamine	  levels	  
o Similar	  80%	  increase	  in	  extracellular	  dopamine	  levels	  
o Similar	  100%	  increase	  in	  extracellular	  DOPAC	  levels	  
- Variable	  eﬀect	  (80-­‐300%	  increase)	  in	  dopamine	  synthesis	  
- Variable	  eﬀect	  (50-­‐200%	  increase)	  in	  *ssue	  DOPAC	  levels	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Introduc)on	   Goal	  
Goal	  is	  to	  determine	  a	  mechanism	  that	  explains	  the	  eﬀects	  
of	  an*psycho*c	  drugs	  on	  dopaminergic	  neurons,	  
speciﬁcally	  the	  variable	  diﬀerences	  in	  dopamine	  synthesis	  
rates	  and	  *ssue	  DOPAC	  levels.	  
Computa)onal	  Model	  
Mechanisms	  
Explana3on	  of	  variable	  3ssue	  DOPAC	  and	  dopamine	  
synthesis	  
- ↑	  leak	  +	  ↑	  cytosolic	  dopamine	  synthesis	  =	  ↑	  cytosolic	  
DOPAC	  
- For	  haloperidol,	  produces	  300%	  increase	  in	  *ssue	  DOPAC	  
and	  380%	  increase	  in	  total	  dopamine	  synthesis	  
- Non-­‐D2	  antagonist	  eﬀects	  –	  second	  recycle	  process	  
Leak	  Support	  
Eﬀects	  of	  vesicle	  alkaliniza3on	  
• Literature	  data	  support	  an*psycho*c	  eﬀects	  on	  vesicles	  
- Haloperidol	  (and	  some	  other	  an*psycho*cs)	  alkalinize	  
vesicles	  
o Moriyama,	  Y.	  Arch	  Biochem	  Biophys	  305:278-­‐281,	  
1993.	  
o Rayport,	  S.	  J	  Neurochem	  65:691-­‐703,	  1995.	  
• Our	  laboratory	  has	  previously	  modeled	  the	  increase	  of	  pH	  
in	  vesicles	  showing	  an	  increased	  eﬄux	  of	  dopamine	  as	  the	  
ﬁgure	  below	  shows	  
Conclusion	  
• D2	  modulates	  exocyto*c	  rate	  
• D2	  modulates	  dopamine	  synthesis	  in	  DOPAC	  secretory	  
synthesis	  complex	  for	  DOPACext	  
• Cytosolic	  dopamine	  synthesis	  is	  modulated	  by	  level	  of	  
dopamine	  in	  vesicles.	  
- ↑	  Leak	  =	  ↑	  in	  cytosolic	  dopamine	  synthesis	  
• Weak,	  lipophilic	  base	  controls	  DOPAC	  *ssue	  and	  total	  
synthesis	  
• New	  synthesis	  regulatory	  mechanism	  =	  dopamine	  in	  
vesicle	  is	  monitored	  and	  synthesis	  adjusts	  to	  keep	  
constant	  level	  
• Tissue	  DOPAC	  is	  not	  an	  accurate	  indicator	  of	  dopamine	  
u*liza*on	  (signaling)	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DRUG	   DA_syncyt	   DA_synsec	   DA_syntot	   Leak	  value	   DOPAC3s	  
Control	   2.88	   1.35	   4.23	   2.7E-­‐04 18,000	  
Sulpiride	   4.34	   2.84	   7.16	   2.7E-­‐04 26,500	  
Clozapine	   6.5	   2.02	   8.52	   3.9E-­‐04 42,700	  
Haloperidol	   12	   3.17	   15.17	   5.4E-­‐04 80,000	  




an*psycho*c	  drugs.	  	  
Increase	  in	  red	  
shading	  shows	  the	  
amount	  of	  increase	  
in	  dopamine	  
synthesis	  elicited	  by	  
the	  drug	  













Explana3on	  for	  increase	  in	  extracellular	  dopamine	  and	  
DOPAC	  levels	  
- ↑	  DAext	  by	  ↑	  Exocytosis	  –	  requires	  1.7	  fold	  increase	  in	  
	  cytosolic	  synthesis	  to	  maintain	  steady	  state	  
- ↑	  DOPACext	  by	  ↑DOPAC	  secretory	  synthesis	  by	  200%	  
- Produces	  about	  150%	  increase	  in	  *ssue	  DOPAC	  
- Produces	  about	  180%	  increase	  in	  total	  dopamine	  synthesis	  
- Mechanism	  completely	  explains	  the	  eﬀects	  of	  sulpiride	  
using	  processes	  known	  to	  be	  regulated	  by	  D2	  receptors	  
This	  table	  shows	  s*mula*on	  values	  of	  three	  an*psycho*c	  drugs	  
